FDA's Cellular, Tissue and Gene Therapies Advisory Committee to Meet on Proposed Rule for Cellular and Tissue-Based Therapies

Summary

The US Food and Drug Administration (FDA) will hold a meeting of its Cellular, Tissue and Gene Therapies Advisory Committee to discuss a proposed rule for cellular and tissue-based therapies, formerly known as the Biological Response Modifiers Advisory Committee